[Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002463:Cell Membrane Permeability / Q000187:drug effects; D002648:Child; D002908:Chronic Disease; D003141:Communicable Diseases / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D011135:Polysaccharides, Bacterial; D011354:Prodigiozan
Primenenie prodigiozana v kompleksnoĭ terapii infektsionnykh zabolevaniĭ (obzor literatury).